NONSMALL CELL LUNG CANCER
Clinical trials for NONSMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NONSMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NONSMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy shows promise in advanced lung cancer battle
Disease control CompletedThis study tested a new immunotherapy drug, cemiplimab, against standard chemotherapy for people with advanced non-small cell lung cancer that has a specific marker (PD-L1). About 700 patients participated. The goal was to see if cemiplimab helps people live longer and keeps the …
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:22 UTC
-
New antibody combo shows promise in Hard-to-Treat cancers
Disease control CompletedThis early-stage study tested a new drug called HMBD-002, alone or with another drug (pembrolizumab), in 48 adults with advanced solid tumors (like lung or breast cancer) that had stopped responding to standard treatments. The main goals were to check safety, find the best dose, …
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated May 26, 2026 04:21 UTC
-
Electric field therapy extends life in advanced lung cancer trial
Disease control CompletedThis phase 3 trial tested a wearable device called Tumor Treating Fields (TTFields) in 291 people with stage 4 non-small cell lung cancer that had worsened after platinum chemotherapy. The device delivers low-intensity electric fields to the tumor area and was used alongside stan…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: NovoCure GmbH • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
Tailored radiation for lung cancer: a small step toward personalized treatment
Knowledge-focused CompletedThis study tested whether it is possible to use a patient's tumor genetics to customize radiation doses for stage 2 or 3 non-small cell lung cancer. Only 3 people took part, and the main goal was to see if this approach was safe and doable. The study was very early-stage and focu…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 04:15 UTC